SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FJB who wrote (1071720)5/31/2018 12:26:39 PM
From: zzpat1 Recommendation

Recommended By
sylvester80

   of 1573302
 
"Currently, the FDA approves 99 percent of all requests made by terminally ill patients for expanded treatment beyond FDA-approved options. The agency oversees the treatment and uses the results to judge the efficacy and safety of the experimental drugs."

There is no testing of Phase 1 drugs to ensure they're working. From the Cancer Society, "Placebos (sham or inactive treatments) are not part of phase I trials."

This new law is an attempt to put drugs on the market that are not safe and will never be safe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News